This technology is a microneedle-endoscope capable of perforating the round window membrane of the inner ear, allowing for drug delivery and sampling of inner ear fluids for therapeutics and diagnostics.
Current methods to sample and/or deliver drugs to the inner ear are largely restricted by their invasiveness and potential long-term complications such as trauma and hearing loss. The round window membrane is a major physical barrier to the inner ear that requires careful consideration to maintain its integrity and prevent long-term damage. Furthermore, methods that allow for both sampling and drug delivery are lacking.
This device is fitted with a microneedle head and leverages endoscopic, camera-guided precision to carefully perforate the round window membrane of the inner ear. Capable of both drug delivery and fluid sampling, this technology safety traverses a major physical barrier to the inner ear without disrupting its structural integrity and mitigating potential long-term concerns such as hearing loss.
Patent Pending(PCT/US2023/061545)
IR CU21365, CU22203, CU22311, CU23068
Licensing Contact: Dovina Qu
